{"id":"https://openalex.org/W2017995451","doi":"https://doi.org/10.1097/00002030-200109070-00020","title":"Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens","display_name":"Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2017995451","doi":"https://doi.org/10.1097/00002030-200109070-00020","mag":"2017995451","pmid":"https://pubmed.ncbi.nlm.nih.gov/11546952"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200109070-00020","doi":"https://doi.org/10.1097/00002030-200109070-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200109070-00020","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076099897","display_name":"Maria Dorrucci","orcid":"https://orcid.org/0000-0002-8543-6430","observed_orcids":["https://orcid.org/0000-0002-8543-6430"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Dorrucci","raw_affiliation_strings":["Istituto Superiore di Sanit\u00e0, Reparto AIDS/MST, Rome, Italy","Istituto Superiore di Sanit\u00e0 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0, Reparto AIDS/MST, Rome, Italy","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0 ,","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042919720","display_name":"Patrizio Pezzotti","orcid":"https://orcid.org/0000-0002-0805-2927","observed_orcids":["https://orcid.org/0000-0002-0805-2927"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizio Pezzotti","raw_affiliation_strings":["Istituto Superiore di Sanit\u00e0, Reparto AIDS/MST, Rome, Italy;","Istituto Superiore di Sanit\u00e0 ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0, Reparto AIDS/MST, Rome, Italy;","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0 ,","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030558704","display_name":"Benvenuto Grisorio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122534668","display_name":"Marche Polytechnic University","ror":"https://ror.org/00x69rs40","country_code":"IT","type":"education","lineage":["https://openalex.org/I122534668"]},{"id":"https://openalex.org/I4210092209","display_name":"Ospedali Riuniti di Foggia","ror":"https://ror.org/00g0x9d29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210092209","https://openalex.org/I4210099368","https://openalex.org/I4210117053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Benvenuto Grisorio","raw_affiliation_strings":["Department of Infectious Diseases, Ospedali Riuniti, Foggia, Italy;","Universit\u00e0 Politecnica delle Marche"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Ospedali Riuniti, Foggia, Italy;","institution_ids":["https://openalex.org/I4210092209"]},{"raw_affiliation_string":"Universit\u00e0 Politecnica delle Marche","institution_ids":["https://openalex.org/I122534668"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113576186","display_name":"Cristina Minardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79940851","display_name":"University of Brescia","ror":"https://ror.org/02q2d2610","country_code":"IT","type":"education","lineage":["https://openalex.org/I79940851"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cristina Minardi","raw_affiliation_strings":["Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy;","University of Brescia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy;","institution_ids":["https://openalex.org/I79940851"]},{"raw_affiliation_string":"University of Brescia","institution_ids":["https://openalex.org/I79940851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023246892","display_name":"M. Stella Muro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159650629","display_name":"University of Sassari","ror":"https://ror.org/01bnjbv91","country_code":"IT","type":"education","lineage":["https://openalex.org/I159650629"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Stella Muro","raw_affiliation_strings":["Institute of Infectious Diseases, University of Sassari, Sassari, Italy;","University of Sassari"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infectious Diseases, University of Sassari, Sassari, Italy;","institution_ids":["https://openalex.org/I159650629"]},{"raw_affiliation_string":"University of Sassari","institution_ids":["https://openalex.org/I159650629"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Vincenzo Vullo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Vullo","raw_affiliation_strings":["Institute of Infectious Diseases, La Sapienza University, Rome, Italy; and","Public Health and Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infectious Diseases, La Sapienza University, Rome, Italy; and","institution_ids":["https://openalex.org/I861853513"]},{"raw_affiliation_string":"Public Health and Infectious Diseases","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078701955","display_name":"Antonella d\u2019Arminio Monforte","orcid":"https://orcid.org/0000-0003-0073-1789","observed_orcids":["https://orcid.org/0000-0003-0073-1789"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Antonella d'Arminio Monforte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5078701955"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3803,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.87524172,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"15","issue":"13","first_page":"1733","last_page":"1736"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8676999807357788,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8676999807357788,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.12780000269412994,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.597000002861023},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.949999988079071},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5559999942779541},{"id":"https://openalex.org/keywords/time-to-discontinuation","display_name":"time to discontinuation","score":0.5879999995231628},{"id":"https://openalex.org/keywords/reasons-for-discontinuation","display_name":"reasons for discontinuation","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.8689409494400024},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.8153208494186401},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.7834917902946472},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7741998434066772},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6832393407821655},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.6148331165313721},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5499659180641174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.468334436416626},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.45767590403556824},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4336090385913849},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.42743241786956787},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.35678035020828247},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3527102470397949},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.32413655519485474},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.30390429496765137},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2645741105079651},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.24230840802192688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18384119868278503},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1459091305732727},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.10228395462036133},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06777462363243103},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/00002030-200109070-00020","doi":"https://doi.org/10.1097/00002030-200109070-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200109070-00020","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:11546952","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11546952","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Comparative Study"},{"id":"pmh:oai:iris.uniroma1.it:11573/83629","doi":null,"is_oa":false,"landing_page_url":"http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000171472800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=0c7ff228ccbaaa74236f48834a34396a","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8399999737739563,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1985646480","https://openalex.org/W2063329141","https://openalex.org/W2092398687","https://openalex.org/W2167644155","https://openalex.org/W2321852728","https://openalex.org/W2332060437","https://openalex.org/W2339219218"],"related_works":["https://openalex.org/W4301854183","https://openalex.org/W2252794542","https://openalex.org/W1892065830","https://openalex.org/W2032588084","https://openalex.org/W2017995451","https://openalex.org/W2082701902","https://openalex.org/W2045296735","https://openalex.org/W4206349574","https://openalex.org/W2008052978","https://openalex.org/W4234790260"],"abstract_inverted_index":{"Data":[0],"from":[1,255,357],"a":[2,210,256,483,508,596,649,672,810,888,993,1047],"cohort":[3,257],"of":[4,19,64,101,112,123,155,166,213,220,227,258,270,282,323,330,332,343,360,366,394,410,429,445,466,476,497,529,553,575,629,634,654,669,678,707,749,794,839,844,871,925,930,934,939,943,948,986,996,1019,1024,1077,1464],"HIV-positive":[5,259],"individuals":[6,40,128,287,297,369,439,801,1034],"who":[7,41,261,298,310,370,710],"were":[8,13,262,379,389,413,422,521,549,555,614,701,732,857,950],"antiretroviral":[9,25,77,263,301,305,661,905],"naive":[10,264],"at":[11,265,312,340,381,455,754],"enrolment":[12,266],"analysed":[14,253],"to":[15,59,151,176,195,363,425,773,876,927,936,945,952,960,1040,1050,1065,1070],"estimate":[16,933,942],"the":[17,21,38,57,96,121,152,164,218,225,324,328,336,344,347,355,358,364,374,382,391,400,426,437,442,486,524,537,551,573,580,583,611,635,664,689,692,738,751,771,842,869,976,1017,1022,1028,1054,1461],"probability":[18,212,219,226,393,748,995,1018],"discontinuing":[20,228,750,795,997],"first":[22,48,337,660,752],"highly":[23,75],"active":[24,76,904],"therapy":[26,78,115,172,759,906],"(HAART)":[27,79,907],"regimen,":[28,65],"comparing":[29,171],"protease":[30,134,909],"inhibitor-":[31],"and":[32,95,99,137,243,280,309,403,405,434,453,510,534,546,563,572,599,620,640,675,717,777,785,831,837,865,970,1000,1069],"non-nucleoside":[33,179,914],"reverse":[34,180,235,915],"transcriptase-containing":[35],"regimens.":[36],"Of":[37,436],"2002":[39,448],"began":[42,276,299],"HAART,":[43,333,1052],"857":[44,655],"(42.8%)":[45,656],"discontinued":[46,89,197,215,373,658],"their":[47,659],"regimen.":[49,493,651,902,1026],"No":[50,519,765],"statistically":[51,1058],"significant":[52,766],"difference":[53,690,767,1013,1055,1068],"was":[54,168,327,349,352,397,468,499,540,587,644,740,760,768,813,973,989,1014,1032,1056],"found":[55,522,769,951,1015],"in":[56,147,203,277,346,441,527,631,663,691,770,878,1016],"time":[58,338,356,772,926,935,944],"discontinuation":[60,148,167,331,396,412,430,700,774,783,845,862,872,928,937,946,1007,1020,1031],"by":[61,71,560,786,900,1021],"specific":[62,72,153,174,427,787,978],"type":[63,1023],"either":[66],"when":[67,170,781,859,1005],"considered":[68],"overall":[69,784],"or":[70,729,913,1010],"reason.":[73],"Although":[74],"is":[80,200],"an":[81,206,300,491,608,681,803,881,1036],"extremely":[82,201],"effective":[83],"regimen":[84,208,302,348,598,662,674,683,730,753,805,812,883,890,1038,1049],"[1\u20133],":[85],"it":[86],"can":[87],"be":[88,196,953,1041,1063],"for":[90,505,515,593,605,637,688,699,734,742,797,820,828,863,866,873,962,975,980,998,1001,1008,1030,1460],"various":[91],"reasons,":[92],"including":[93],"toxicity":[94,702,864,1009],"extensive":[97],"duration":[98,465,496],"complexity":[100],"treatment":[102,727],"[4,5].":[103],"Several":[104],"population-based":[105],"studies":[106,125,140],"have":[107,141],"shown":[108],"that":[109,163,177,204,339],"approximately":[110,954],"25%":[111],"patients":[113,260,477,506,554,630,647,657],"discontinue":[114,961,1051],"within":[116],"8\u201312":[117],"months":[118,470,501,512],"[5\u20137],":[119],"but":[120],"populations":[122],"such":[124],"mainly":[126,726],"included":[127],"treated":[129],"only":[130,295],"with":[131,173,178,209,240,249,303,807,885,992],"regimens":[132,191,231],"containing":[133,232,245,908],"inhibitors":[135,182,237],"(PI),":[136],"very":[138],"few":[139],"assessed":[142],"whether":[143,188],"there":[144],"are":[145,192],"differences":[146,520],"rates":[149],"according":[150,424],"combination":[154],"drugs":[156,306,345],"used.":[157],"One":[158],"recent":[159],"study":[160,275,665],"[8]":[161],"reported":[162,733],"rate":[165],"similar":[169,858],"PI":[175,242,509],"transcriptase":[181,236,916],"(NN":[183],"RTI).":[184],"Additional":[185,1060],"knowledge":[186],"about":[187],"certain":[189],"HAART":[190,229,362,395,411,452,796],"more":[193],"likely":[194,957,1043],"than":[198,958,1044],"others":[199],"important,":[202],"choosing":[205],"initial":[207,375,901,1025],"lower":[211],"being":[214],"would":[216],"increase":[217],"therapeutic":[221],"success.":[222],"To":[223],"compare":[224],"between":[230,523,579,775],"two":[233,246,525,581,693],"nucleoside":[234],"(NRTI)":[238],"combined":[239,248],"one":[241,250,314,342,457,755],"those":[244,296,516,594,606,670,679,709,808,879,886,1045],"NRTI":[247],"NNRTI,":[251],"we":[252],"data":[254],"(the":[267],"Italian":[268,443,1075,1462],"Cohort":[269,444,1076,1463],"Antiretroviral-Naive":[271,446,1078,1465],"Patients)":[272],"[9].":[273],"The":[274,291,320,420,463,474,494,566,627,696,746,791,855],"March":[278],"1997,":[279],"as":[281,335,354],"31":[283],"May":[284],"2000,":[285],"4300":[286,438],"had":[288,371,450],"been":[289],"enrolled.":[290],"present":[292],"analysis":[293,326,387],"includes":[294],"three":[304,977],"(i.e.":[307,431,725],"HAART)":[308],"underwent":[311,454],"least":[313,341,456],"follow-up":[315,377,458,467,498,1061],"visit":[316,459],"after":[317,460,757],"starting":[318,361,461],"therapy.":[319,462],"main":[321,697],"endpoint":[322],"statistical":[325],"date":[329,359,365],"defined":[334,353],"terminated.":[350],"Time-to-event":[351],"discontinuation.":[367,981],"For":[368],"not":[372,1057],"combination,":[376],"times":[378],"censored":[380],"last":[383],"clinical":[384],"visit.":[385],"Survival":[386],"methods":[388],"applied:":[390],"cumulative":[392,747],"estimated":[398,414],"using":[399],"Kaplan\u2013Meier":[401,898],"method,":[402],"crude":[404,792],"adjusted":[406],"relative":[407],"hazards":[408,418],"(RH)":[409],"applying":[415],"Cox":[416],"proportional":[417],"models.":[419],"analyses":[421],"repeated":[423],"reason":[428,739,788,799,964,1029],"toxicity,":[432],"failure":[433,712,874,999],"non-compliance).":[435],"enrolled":[440],"Patients,":[447],"(46.7%)":[449],"begun":[451],"median":[464,495,538,567],"9.7":[469],"(range":[471,502,513,543,591,603,618,624],"0.10\u201335.9":[472,503],"months).":[473],"majority":[475,552],"(n":[478,703,713,719],"=":[479,704,714,720,850],"1709);":[480],"85.4%":[481],"initiated":[482,490],"PI-containing":[484,597,650,673,776,811,889,1048],"regimen;":[485,610],"remaining":[487],"293":[488],"(14.6%)":[489],"NNRTI-containing":[492,609,682,778,804,882,1037],"11.0":[500],"months)":[504],"receiving":[507,517],"5.6":[511],"0.10\u201327.0)":[514],"NNRTI.":[518],"groups":[526],"terms":[528],"demographic":[530],"characteristics":[531],"(age,":[532,823],"sex,":[533,824],"exposure":[535,825],"category):":[536],"age":[539],"35":[541],"years":[542],"18\u201370":[544],"years)":[545],"nearly":[547],"70%":[548],"men;":[550],"injection":[556],"drug":[557],"users,":[558],"followed":[559],"heterosexual":[561],"contacts":[562],"homosexual":[564],"contacts.":[565],"baseline":[568,984],"CD4":[569,584,834],"cell":[570,585,835],"count":[571,586,836],"number":[574,838,985],"HIV-RNA":[576,612,840,987],"copies":[577,988],"differed":[578],"groups:":[582],"290":[588],"\u00d7":[589,601],"106/L":[590],"1\u20131439)":[592],"undergoing":[595,607,648,671,680,802,809,880,887,1035,1046],"428":[600],"106/l":[602],"4\u20131402)":[604],"levels":[613],"4.7":[615],"log10":[616,622],"copies/ml":[617,623],"1.1\u20136.7)":[619],"4.4":[621],"1.7\u20136.3),":[625],"respectively.":[626],"proportion":[628],"stage":[632],"C":[633],"Centers":[636,827],"Disease":[638,829],"Control":[639,830],"Prevention":[641,832],"classification":[642],"[10]":[643],"higher":[645,983,994],"among":[646,800],"A":[652,982],"total":[653],"period:":[666],"777":[667],"(45.5%)":[668],"80":[676],"(27.3%)":[677],"[95%":[684],"confidence":[685],"interval":[686],"(CI)":[687],"percentages":[694],"12.4\u201323.6%].":[695],"reasons":[698,724,979],"366;":[705],"42.7%":[706],"all":[708],"discontinued),":[711],"244;":[715],"28.5%),":[716],"non-compliance":[718],"197;":[721],"23.0%);":[722],"other":[723],"intensification":[728],"simplification)":[731],"26":[735],"(3.0%)":[736],"patients;":[737],"unknown":[741],"24":[743],"(2.8%)":[744],"patients.":[745],"year":[756],"initiating":[758],"37.6%":[761],"(95%":[762,815],"CI":[763,816,853,895,968],"25.3\u201339.9%).":[764],"regimens,":[779],"both":[780],"considering":[782,860,1006],"(Fig.":[789],"1).":[790],"RH":[793,843,849,870,892],"any":[798,963],"compared":[806,884],"0.97":[814],"0.77\u20131.22%).":[817],"When":[818,1027],"adjusting":[819],"possible":[821],"confounders":[822],"category,":[826],"stage,":[833],"copies),":[841],"slightly":[846],"decreased":[847],"(adjusted":[848,891],"0.85;":[851],"95%":[852,894,967],"0.63\u20131.15%).":[854],"results":[856],"separately":[861],"non-compliance,":[867,1011],"whereas":[868],"tended":[875,1039],"decrease":[877],"0.61;":[893],"0.31\u20131.20%).Fig.":[896],"1.:":[897],"curves":[899],"Highly":[903],"inhibitor":[910,917],"(PI,":[911],"\u2014)":[912],"(NNRTI,":[918],"-":[919,920,921],"-).":[922],"(a)":[923],"Estimate":[924],"because":[929,938,947],"toxicity;":[931],"(b)":[932],"failure;":[940],"(c)":[941],"non-compliance.Men":[949],"30%":[955],"less":[956,1042],"women":[959],"(RH":[965],"0.77;":[966],"0.64\u20130.94%),":[969],"this":[971,1067],"tendency":[972],"confirmed":[974],"significantly":[990],"associated":[991],"non-compliance.":[1002],"In":[1003],"conclusion,":[1004],"no":[1012],"failure,":[1033],"although":[1053],"significant.":[1059],"will":[1062],"necessary":[1064],"confirm":[1066],"determine":[1071],"its":[1072],"reasons.":[1073],"*The":[1074],"Patients":[1079,1466],"Study":[1080,1467],"Group":[1081],"Italy:":[1082],"Ancona:":[1083],"M.":[1084,1165,1205,1230,1269,1271,1317,1372,1377,1383,1396,1412,1452],"Montroni,":[1085],"G.":[1086,1097,1100,1121,1133,1135,1158,1183,1196,1217,1238,1295,1334,1352,1356,1379,1391,1424,1435],"Scalise,":[1087],"A.":[1088,1145,1160,1200,1215,1220,1222,1225,1232,1234,1242,1265,1286,1312,1322,1328,1354,1366,1401,1406,1422,1439],"Costantini,":[1089],"M.S.":[1090,1394],"Del":[1091,1370],"Prete;":[1092],"Aviano":[1093],"(PN):":[1094],"U.":[1095],"Tirelli,":[1096],"Nasti;":[1098],"Bari:":[1099],"Pastore,":[1101],"M.L.":[1102,1408],"Perulli;":[1103],"Bergamo:":[1104],"F.":[1105,1110,1125,1150,1168,1173,1175,1210,1227,1236,1247,1307,1315,1320,1350,1381,1399,1432],"Suter,":[1106],"C.":[1107,1116,1127,1255,1260,1325,1419],"Arici;":[1108],"Bologna:":[1109],"Chiodo,":[1111],"F.M.":[1112],"Gritti,":[1113],"V.":[1114,1274,1288,1364],"Colangeli,":[1115],"Fiorini,":[1117],"L.":[1118,1155,1170,1212,1240,1297,1338,1348,1369],"Guerra;":[1119],"Brescia:":[1120],"Carosi,":[1122],"G.P.":[1123],"Cadeo,":[1124],"Castelli,":[1126],"Minardi,":[1128],"D.":[1129,1417],"Vangi;":[1130],"Busto":[1131],"Arsizio:":[1132],"Rizzardini,":[1134,1239],"Migliorino;":[1136],"Cagliari:":[1137],"P.E.":[1138],"Manconi,":[1139],"P.":[1140,1163,1191,1193,1281,1360,1374,1389,1404],"Piano;":[1141],"Catanzaro:":[1142],"T.":[1143,1290,1332],"Ferraro,":[1144],"Scerbo;":[1146],"Chieti:":[1147],"E.":[1148,1276,1310,1387,1427],"Pizzigallo,":[1149],"Ricci;":[1151],"Como:":[1152],"G.M.":[1153],"Vigevani,":[1154],"Pusterla;":[1156],"Cremona:":[1157],"Carnevale,":[1159],"Pan;":[1161],"Cuggiono:":[1162],"Vigan\u00f2,":[1164],"Mena;":[1166],"Ferrara:":[1167],"Ghinelli,":[1169],"Sighinolfi;":[1171],"Firenze:":[1172],"Leoncini,":[1174],"Mazzotta,":[1176],"S.":[1177,1179,1187,1207,1245,1253,1278,1292,1305,1345,1358,1410,1429],"Ambu,":[1178],"Lo":[1180],"Caputo;":[1181],"Foggia:":[1182],"Angarano,":[1184],"B.":[1185,1249,1251,1414],"Grisorio,":[1186],"Ferrara;":[1188],"Galatina":[1189],"(LE):":[1190],"Grima,":[1192],"Tundo;":[1194],"Genova:":[1195],"Pagano,":[1197],"N.":[1198,1263,1362],"Piersantelli,":[1199],"Alessandrini,":[1201],"R.":[1202,1258,1283,1302,1343],"Piscopo;":[1203],"Grosseto:":[1204],"Toti,":[1206],"Chigiotti;":[1208],"Latina:":[1209],"Soscia,":[1211],"Tacconi;":[1213],"Lecco:":[1214],"Orani,":[1216],"Castaldo;":[1218],"Lucca:":[1219],"Scasso,":[1221],"Vincenti;":[1223],"Mantova:":[1224],"Scalzini,":[1226],"Alessi;":[1228],"Milano:":[1229],"Moroni,":[1231],"Lazzarin,":[1233],"Cargnel,":[1235],"Milazzo,":[1237],"Caggese,":[1241],"d'Arminio":[1243,1458],"Monforte,":[1244],"Melzi,":[1246],"Delfanti,":[1248],"Carini,":[1250],"Adriani,":[1252],"Garavaglia,":[1254],"Moioli;":[1256],"Modena:":[1257],"Esposito,":[1259],"Mussini;":[1261],"Napoli:":[1262],"Abrescia,":[1264],"Chirianni,":[1266],"O.":[1267],"Perrella,":[1268],"Piazza,":[1270],"De":[1272,1326,1367,1375,1433],"Marco,":[1273],"Montesarchio,":[1275],"Manzillo,":[1277],"Nappa;":[1279],"Padova:":[1280],"Cadrobbi,":[1282],"Scaggiante;":[1284],"Palermo:":[1285],"Colomba,":[1287],"Abbadesse,":[1289],"Prestileo,":[1291],"Mancuso;":[1293],"Pavia:":[1294],"Filice,":[1296],"Minoli,":[1298],"F.A.":[1299],"Patruno":[1300],"Savino,":[1301],"Maserati;":[1303],"Perugia:":[1304],"Pauluzzi,":[1306],"Baldelli;":[1308],"Pesaro:":[1309],"Petrelli,":[1311],"Cioppi;":[1313],"Piacenza:":[1314],"Alberici,":[1316],"Sisti;":[1318],"Pisa:":[1319],"Menichetti,":[1321],"Smorfa;":[1323],"Potenza:":[1324],"Stefano,":[1327],"La":[1329],"Gala;":[1330],"Ravenna:":[1331],"Zauli,":[1333],"Ballardini;":[1335],"Reggio":[1336],"Emilia:":[1337],"Bonazzi,":[1339],"M.A.":[1340],"Ursitti;":[1341],"Rimini:":[1342],"Ciammarughi,":[1344],"Giordani;":[1346],"Roma:":[1347],"Ortona,":[1349],"Dianzani,":[1351],"Ippolito,":[1353],"Antinori,":[1355],"Antonucci,":[1357],"D'Elia,":[1359],"Narciso,":[1361],"Petrosillo,":[1363],"Vullo,":[1365],"Luca,":[1368],"Forno,":[1371],"Zaccarelli,":[1373],"Longis,":[1376],"Ciardi,":[1378],"D'Offizi,":[1380],"Palmieri,":[1382],"Lichtner,":[1384],"M.R.":[1385],"Capobianchi,":[1386],"Girardi,":[1388],"Pezzotti,":[1390],"Rezza;":[1392],"Sassari:":[1393],"Mura,":[1395],"Mannazzu;":[1397],"Taranto:":[1398],"Resta,":[1400],"Chimienti;":[1402],"Torino:":[1403],"Caramello,":[1405],"Sinicco,":[1407],"Soranzo,":[1409],"Quaglia,":[1411],"Sciandra,":[1413],"Salassa;":[1415],"Varese:":[1416],"Torre,":[1418],"Basilico;":[1420],"Verbania:":[1421],"Poggio,":[1423],"Bottari;":[1425],"Venezia:":[1426],"Raise,":[1428],"Pasquinuci;":[1430],"Vicenza:":[1431],"Lalla,":[1434],"Tositti.":[1436],"UK:":[1437],"London:":[1438],"Cozzi":[1440],"Lepri,":[1441],"A.N.":[1442],"Phillips.":[1443],"Maria":[1444],"Dorruccia":[1445],"Patrizio":[1446],"Pezzottia":[1447],"Benvenuto":[1448],"Grisoriob":[1449],"Cristina":[1450],"Minardic":[1451],"Stella":[1453],"Murod":[1454],"Vincenzo":[1455],"Vulloe":[1456],"Antonella":[1457],"Monfortef":[1459],"Group*":[1468]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}